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Regenerative frontiers in craniofacial reconstruction: grand 
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Science’s fascination with bone and its repair processes span for thousands of years since 
the ancient Greek Hippocrates, the father of Medicine, made the key discovery that bone 
heals without scarring. Through the centuries, several lucid investigators perceived that the 
extracellular matrix of bone must be a reservoir of differentiating and morphogenetic factors 
ultimately responsible for its pronounced healing potential (reviewed in Urist, 1968, 1994; Reddi, 
2000; Ripamonti et al., 2006).
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Trueta also referred to von Haller (1763) who has hypothesized 
that the vascular system is responsible for osteogenesis (Trueta, 
1963). Later, during last century, Keith (1927) has suggested that 
“bone-forming cells are derived from the endothelium of invading 
capillaries.” The possibility that bone-forming cells, or osteoblasts, 
are derived from the endothelium is morphologically presented 
in Figure 1A; endothelial-like cells are shown to migrate from 
the vascular compartment to the osteoblastic/bone-forming 
compartment actively secreting the newly formed bone matrix 
(Figure 1A). Long before von Haller, Keith, and Trueta, the mul-
tifaceted eclectic personality of Aristotle as quoted by Lanza and 
Vegetti (1971) and Crivellato et al. (2007) credited the sprouting 
blood vessels with a patterning function during organogenesis. 
Figure 1A also shows morphologically the plasticity of the migrat-
ing endothelial cells and the superbly intimate relationships of 
the endothelium and its basement membrane with the secreting 
osteoblastic-like cells.
Majestically, Aristotle credited the sprouting capillaries with pat-
terning functions during organogenesis and that the architectural 
patterning of vessel growth functions as a “frame” or “model” to 
shape the body structure. The Aristotelian scenario of pattern-
ing organogenetic capillaries is highlighted in Figures 1B–D.; the 
sprouting capillaries are soon surrounded by mesenchymal cellular 
condensations progressively closing around the invading capillaries 
(Figure 1C); the vessels are thus “morphogenetic” since initiate 
the morphogenesis of cellular condensations, i.e., it is the vessel 
that sets into motion the ripple-like cascade of tissue condensa-
tions thus providing cellular elements for cross-talking at cellular 
and transmembrane receptor levels with both the endothelial and 
pericytic paravascular cells of the “morphogenetic” and “osteoge-
netic” vessels of Aristotle’s and Trueta’s definitions (Figures 1B–D) 
(Trueta, 1963). This Aristotelian patterning scenario of sequential 
inductive and differentiating cascades of molecular and cellular 
Historical PersPective
Restoring anatomical function of complex disfiguring craniofacial 
defects and anomalies remains a grand unsolved challenge. Those 
of us who have not suffered the outrage of facial deformity visited 
upon patients either as a developmental misfortune or the scourge 
of disease or violence can only imagine the effects thereof. Loss of 
facial features not only denies patients the most basic human func-
tions but also rob them of a sense of identity with all the associated 
mental anguish.
Bone has fascinated a plethora of scientists throughout the world 
since the bone matrix is in both soluble and insoluble states (Reddi, 
1997); in his classic Cell’s contribution, Reddi states that there is 
a continuum between the soluble and insoluble states of the bone 
matrix that is regulated by signals in solution interacting with the 
insoluble signals of the extracellular matrix (Reddi, 1997).
The bone and the skeleton evolved for several purposes, prima-
rily for the emergence of the vertebrates, body erection and locomo-
tion, copulation, for protection of the brain, the spinal cord and the 
hematopoietic marrow and as reservoir of vital ions such as cal-
cium, phosphate, magnesium and zinc (Reddi, 1997). Body erection 
freed the upper limbs for superior foraging and more industrious 
Homo-like activities including the use of tools for hunting, forag-
ing above all, however, for maternal care, contributing thus to the 
speciation of the genus Homo ultimately directing the emergence 
of the Homo clade.
What it is that confers to the skeleton and its bones this remark-
able repair potential known since Hippocratic times? Importantly, 
normal and pathologic bone modeling and remodeling are inexo-
rably tied to angiogenesis (Saadeh et al., 1999). Angiogenesis is a 
prerequisite for osteogenesis (Trueta, 1963). In his studies, Trueta 
presented the critical role of the vessels in osteogenesis and defined 
the “osteogenetic vessel” as critically important differentiating 
vessels having a profound osteogenic function (Trueta, 1963). 
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Senn two centuries ago lucidly saw that postnatal bone regenera-
tion after implantation of decalcified bone matrix develops via 
embryonic tissue formation.
Trueta’s (1963) morphologically superb studies on the influ-
ence of angiogenesis in osteogenesis have seeded several areas 
of research interest as well as providing an opinion paper on 
the critical role of the vessels in osteogenesis. Levander and 
collaborators provided a series of investigations reporting the 
heterotopic intramuscular induction of bone formation by eth-
anol-treated and partially extracted bone matrices (Levander, 
1938). It is our opinion that in spite of the grand published 
research work, Levander did not reach the deserved fame simply 
by failing to provide a name for the hypothesized “substance 
with bone-forming properties” (Levander, 1938; Levander and 
Willestaedt, 1946). Levander stated that heterotopic intramus-
cular formation of bone is induced by “some substance extracted 
by alcohol from the skeletal tissue, a substance having the power 
to activate the non-specific mesenchymal tissue into the forma-
tion of bone tissue, either directly or via the embryonic prena-
tal stage of bone, viz. cartilage” (Levander, 1938; Levander and 
Willestaedt, 1946).
Levander (Levander, 1938; Levander and Willestaedt, 1946) 
clearly identified that the induction of bone formation in post-
natal life recapitulates events that occur in the normal course of 
embryonic development (Levander, 1938). Levander (1945) went 
events is cathartically condensed and summarized by the fascinat-
ing scenario of “bone: formation by autoinduction” (Urist, 1965; 
Reddi and Huggins, 1972).
Bone: Formation By autoinduction
The history and chronicle of the scientific discoveries on the heal-
ing potential of bone is rich with significant advances that have 
repeatedly shaped our understanding of bone tissue engineering 
and regeneration. Due to constraints of space, the interested reader 
is encouraged to read the path of discoveries that have characterized 
the evolution of bone tissue engineering (Urist, 1994; Reddi, 2000; 
Ripamonti et al., 2006).
Seminal research work has been published by several scientists 
around the globe though it is difficult to chart a non-opinionated 
historical perspective on the studies of bone regeneration. We 
will enjoy, however, following a trial of references back through 
the centuries at least recognizing some landmark discoveries and 
developments.
Senn (1889) implanted decalcified antiseptic bone to treat skull 
defects in a canine model; in his futuristic classic work, Senn dem-
onstrated the value of implanting disks or plates of decalcified bone 
in canine calvarial defects. Astutely, Senn noticed that the implanted 
decalcified matrix was incorporated by a large mass of embryonic 
tissue, a condition he has stated, favorable to the formation of new 
bone at the site of implantation of decalcified bone (Senn, 1889). 
Figure 1 | Angiogenesis, capillary sprouting, vascular invasion, cellular 
trafficking, cell differentiation and the induction of the primate cortico-
cancellous osteonic bone. (A) Endothelial-like cell detachment and migration 
from the vascular compartment (magenta arrow) to the bone-forming osteogenetic 
compartment (top right of magenta arrow); (B–D) osteogenesis in angiogenesis in 
the non-human primate Papio ursinus. Capillary sprouting and invasion patterning 
the induction of mesenchymal cellular condensations around the “osteogenetic 
vessels” of Trueta’s definition (Trueta, 1963); (B) Mesenchymal condensations (light 
blue arrow) patterned around the invading osteogenetic vessels with foci of 
mineralization (dark blue arrow) facing osteoid seems populated by differentiating 
osteoblast-like cells; (C,D) Tissue patterning and morphogenesis as induced by the 
osteogenetic vessels with newly forming mesenchymal condensations patterning 
around the central morphogenetic vessels (light blue arrow in C and D) with foci of 
mineralization of the newly formed bone (dark blue arrows).
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and, as per Urist speculation, of a bone morphogenetic protein 
complex within the bone matrix (Urist and Strates, 1971). The 
identification of this elusive bone morphogenetic protein complex 
has been hindered by the fact that the extracellular matrix of bone 
exists in the solid state (Reddi, 1997) and by the limited quantities 
of putative morphogenetic proteins within the extracellular matrix 
of bone tightly bound to the organic and inorganic components 
of the bone matrix (Sampath and Reddi, 1984).
Fundamental steps forward were the studies by Reddi and 
Sampath who identified the elusive proteins to be part of the extra-
cellular matrix of bone. The bone matrix in the solid state was dem-
ineralized to show the endochondral osteoinductivity of the crude 
bone matrix preparations (Reddi and Huggins, 1972; Sampath and 
Reddi, 1981; Reddi, 1984); the demineralized bone matrix was then 
dissociatively extracted with chaotropic agents such as guanidin-
ium hydrochloride and/or urea; the extracted intact bone matrix 
yielded a soluble signal, i.e., the proteinaceous component, and an 
insoluble signal or substratum, i.e., mainly insoluble collagenous 
bone matrix, inactive after the extraction of the osteogenic proteins 
(Sampath and Reddi, 1981); both signals, when singly implanted 
subcutaneously in the rodent bioassay, were inactive (Sampath and 
Reddi, 1981). This implied that the osteogenic activity of the intact 
demineralized bone matrix was lost after the dissociative extraction 
of the matrix components (Sampath and Reddi, 1981).
The realization that the bone matrix could be dissociatively 
extracted and that the extracted components could be recom-
bined, more figuratively reconstituted with the insoluble collagen-
ous component or residue restoring the biological activity of the 
crude but intact demineralized bone matrix preparations, showed 
unequivocally that the extracellular matrix of bone is a reservoir 
of morphogenetic soluble signals that per se initiate the cascade of 
bone differentiation by induction (Sampath and Reddi, 1981, 1983; 
Ripamonti and Reddi, 1995; Reddi, 2000). Additionally and impor-
tantly, the classic studies of Sampath and Reddi showed that the 
soluble signals need to be reconstituted with an insoluble signal or 
substratum to trigger the ripple-like cascade of bone differentiation 
by induction (Sampath and Reddi, 1981, 1983; Reddi, 2000). The 
operational reconstitution of the soluble signals with an insoluble 
signal or substratum (Sampath and Reddi, 1981, 1983; Ripamonti 
and Reddi, 1995) was a key experiment that propelled the bone 
induction principle into the pre-clinical and clinical arenas provid-
ing a bona fide bioassay for putative osteogenic proteins (Sampath 
and Reddi, 1981, 1983; Ripamonti and Reddi, 1995; Reddi, 2000).
The experimental work of Reddi’s group established what it is 
now known as the tissue engineering paradigm whereby soluble 
molecular signals are recombined with insoluble signals or sub-
strata to trigger the ripple-like cascade of bone differentiation by 
induction (Sampath and Reddi, 1981, 1983; Khouri et al., 1991; 
Reddi, 2000). Importantly, restoration of the biological activity 
of osteogenic proteins in the rat subcutaneous bioassay was also 
possible by reconstituting xenogeneic homologous proteins provid-
ing that the solubilized proteins are reconstituted with the recipi-
ent rodent allogeneic insoluble collagenous matrix (Sampath and 
Reddi, 1983). This implied that there are homologous inductive 
proteins across mammalian species whereas the insoluble collagen-
ous bone matrix retains the antigenic load and that the initiation 
further by introducing the term “tissue induction” by this as yet 
unknown substance he has hypothesized to be present within the 
bone matrix.
Years later Lacroix (1945) has had the vision to at least propose 
a short concise term for this morphogenetic still unknown factor. 
Lacroix (1945) has named this osteogenic substance within the bone 
matrix or, prophetically, a group of substances with bone-forming 
properties, as “osteogenins.” Of note, Lacroix letter to Nature depre-
ciated all the hard work of the Swedes, for at least 10 years before 
Lacroix’ letter, Levander and co-workers have unequivocally dem-
onstrated the induction of bone formation using alcoholic extracts 
of bone matrix (M. R. Urist, personal communication; Levander, 
1938, 1945; Levander and Willestaedt, 1946).
We are of the opinion that also Moss (1958) significantly con-
tributed by reporting in Science on the “extraction of an osteogenic 
inductor from bone.” The seminal work of Urist (1965), adding to 
the previously published experimental work of Levander, Lacroix, 
Moss and borrowing the term induction from Spemann (1938) and 
Levander (1945), provided the reproducible evidence that heterotopic 
intramuscular implantation of allogeneic demineralized bone matrix 
in rodents, lagomorphs and into a variety of orthotopic bony defects 
in humans results in the induction of bone formation (Urist, 1965). 
His visionary work on “bone: formation by autoinduction” has been 
immortalized by his classic 1965 Science’s paper (Urist, 1965). The 
important vision of Urist was the introduction of the morphogenetic 
concept of a hypothetical bone morphogenetic protein complex within 
the bone matrix that would initiate the genesis of form and function, 
i.e., bone morphogenesis. Because of his continuous studies on the 
induction of bone formation in a variety of animal models including 
humans but particularly in our opinion for the selection of the ideal 
term “bone morphogenetic protein” (Urist and Strates, 1971) he has 
claimed the fame to be the initiator of the “bone induction principle,” 
a term Urist himself has set in the sixties (Urist et al., 1967, 1968).
Reddi and his team excelled by thoroughly investigating the 
biochemical and morphological cascades of bone differentiation 
by induction (Reddi and Huggins, 1972; Reddi, 1984) and ventur-
ing into partial purification of these still “elusive” morphogenetic 
factors (Sampath and Reddi, 1981, 1983; Sampath et al., 1987).
Important studies showed that osteogenesis is also induced by 
transplantation of the urinary bladder, ligation of the renal arteries, 
or surgical lesions of the wall of the urinary bladder. Huggins (1968) 
and Friedenstein (1968) excelled in their own right by publish-
ing classic papers on the fascinating phenomenon of uroepithelial 
osteogenesis. Friedenstein ultimately asked the compelling question 
that eventually has defined the “bone induction principle” and the 
“osteogenic activity” of several transplanted matrices, including 
bone, dentine, and uroepithelium. How is the inductive influence of 
the transitional epithelium and other matrices including deminer-
alized bone and dentine transferred to the competent responding 
cells? Friedenstein’s elegant research on transfilter bone induction 
naturally implied the presence of a soluble “inductor,” i.e., a diffus-
ible soluble molecular signal ultimately responsible for the induc-
tion of bone formation (Friedenstein, 1962).
The grand work of Urist and Reddi provided the reproduc-
ible evidence of the osteogenic activity of demineralized bone and 
dentine matrices implying the presence of morphogenetic factors 
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in heterotopic sites of rodents, lagomorphs and canine models 
does not induce endochondral bone differentiation but rather a 
pronounced fibrogenic response without any evidence of bone 
formation (Roberts et al., 1986).
In recent years, several different studies have cast a new light 
on the specific role of TGF-β isoforms within the bone matrix. 
Balooch et al. showed that TGF-β regulates the mechanical prop-
erties and composition of the bone matrix. There is also a direct 
relationship between the regulation of gene expression by TGF-β 
and the mechanical properties of the bone matrix of endochondral 
or intramembranous origin (Balooch et al., 2005). Similarly, mRNA 
expression of TGF-β gene products is essential for joint morpho-
genesis (Spagnoli et al., 2007). Joint morphogenesis with regenera-
tion of the entire articular surface of the rabbit synovial joint has 
been recently shown after cell recruitment and “homing” initiated 
by the hTGF-β
3
 isoform (Lee et al., 2010). We have also learned that 
the mammalian TGF-β isoforms are critical for the control and 
initiation of angiogenesis by modulating the expression of vascular 
endothelial growth factor by osteoblasts and osteoblastic-like cells 
(Saadeh et al., 1999).
Systematic studies in the non-human primate P. ursinus have 
shown a previously unknown function of the mammalian TGF-β 
isoforms, i.e., the induction of endochondral bone formation, 
defined as the de novo generation of endochondral bone in het-
erotopic, intramuscular sites (Ripamonti et al., 1997, 2000, 2008; 
Ripamonti and Roden, 2010). This is in marked contrast to stud-
ies in rodents and lagomorphs where only fibrogenic effects are 
observed (Roberts et al., 1986). Our studies on the presence of 
multiple forms of osteogenic proteins of the TGF-β superfamily 
have confirmed that homologous but molecularly different protein 
isoforms of the TGF-β supergene family, conserved in structure but 
diverse in ligand recognition (Sun, 2003), control tissue induction 
and morphogenesis of endochondral bone formation (Ripamonti 
et al., 1997, 2000, 2008; Ripamonti and Roden, 2010).
Heterotopic intramuscular implantation of doses of hTGF-β
3
 
in P. ursinus results in the rapid induction of large and cortical-
ized ossicles by day 30 and 90 after implantation (Figure 2). Hyper 
cellular osteoblastic activity, osteoid synthesis, angiogenesis and 
prominent capillary sprouting have suggested a novel molecular 
and morphological basis for the induction of bone formation in 
clinical contexts (Ripamonti et al., 2008). Our laboratories have also 
shown substantial induction of bone formation with mineraliza-
tion of the newly formed bone as early as 30 days after implanta-
tion in non-healing full thickness mandibular defects of P. ursinus 
(Ripamonti, 2006b, The Marshall Urist Awarded Lecture), confirm-
ing that the hTGF-β
3
 isoform is the most powerful osteoinductive 
morphogen so far tested in non-human primates of the species P. 
ursinus (Ripamonti et al., 2008; Ripamonti, 2010).
cHallenges and oPPortunities For tHe  
tgF-β3 – osteogenic device
The greatest challenge of regenerative medicine and bone tissue 
engineering is to translate in clinical contexts what has been so 
dramatically discovered in pre-clinical animal models as well as 
on the laboratory bench (Reddi, 2000; Ripamonti et al., 2007). 
Reconstruction of large craniofacial defects in humans requires 
the harvesting of autogenous bone grafts from a distant donor site 
of bone formation is only triggered when using allogeneic but not 
xenogeneic collagenous bone matrix preparations (Sampath and 
Reddi, 1983; Ripamonti and Reddi, 1995).
The realization that the putative and elusive osteoinductive 
proteins were tightly bound to the bone matrix and could be dis-
sociatively extracted and reconstituted with an insoluble signal or 
substratum, set into motion the race for the purification of the 
osteogenic proteins which culminated in the isolation, sequencing 
and cloning of an entirely new family of protein initiators collectively 
called the bone morphogenetic/osteogenic proteins (BMPs/OPs); 
BMPs/OPs belong to the transforming growth factor-β (TGF-β) 
supergene family (Wozney et al., 1988; Özkaynak et al., 1990; Reddi, 
2000; Ripamonti et al., 2004; Ripamonti, 2006a). Molecular cloning 
of the now available recombinant human proteins, i.e., BMP-2 and 
BMP-7, the latter also known as osteogenic protein-1 (OP-1), has 
allowed extensive testing in pre-clinical and clinical contexts, from 
laboratory benches to non-human and human primates (Reddi, 
2000; Ripamonti et al., 2000, 2007; Friedlander et al., 2001; Govender 
et al., 2002; Ripamonti, 2006a, 2010).
redundancy: multiPle molecular signals initiating 
tHe induction oF Bone Formation
Bone tissue engineering in clinical contexts has proven however 
to be an elusive target when compared to results obtained in pre-
clinical studies including non-human primate species (Ripamonti 
et al., 2007). The induction of bone formation by recombinant 
hBMPs/OPs has dramatically shown that regenerative medicine in 
clinical contexts is on a different scale altogether when compared 
to animal models that may not adequately translate and reproduce 
morphogens-related therapeutic responses in Homo sapiens yield-
ing uninspiring amounts of newly induced bone often compara-
tively lower than autogenous bone grafts (Garrison et al., 2007; 
Gautschi et al., 2007; Ripamonti et al., 2007).
Importantly, implantation of recombinant hOP-1 in the non-
human primate Papio ursinus resulted in the expression of OP-1, 
BMP-3 and TGF-β
1
 mRNAs as evaluated by Northern blot analy-
ses (Ripamonti, 2005). The reported data showed a temporal and 
spatial pattern of gene expression which has indicated progressing 
stages of osteogenic differentiation during the initiation of bone 
formation by increasing doses of the hOP-1 osteogenic device 
(Ripamonti, 2005). It was noteworthy that there was a temporal 
and spatial expression pattern of TGF-β
1 
mRNAs with a relatively 
high expression on day 30 when compared to low expression pat-
terns on day 15 and 90 indicating the presence of a specific temporal 
window during which expression of TGF-β
1
 mRNA is mandatory 
for optimal osteogenesis (Ripamonti, 2005).
The importance of the TGF-β proteins has been dramati-
cally shown by the synergistic interaction with hOP-1 to induce 
massive heterotopic and orthotopic ossicles in the non-human 
primate P. ursinus (Ripamonti et al., 1997; Duneas et al., 1998); 
surprisingly and in marked contrast to other animal models, it was 
also found that recombinant or platelet-derived TGF-β
1
 induce 
endochondral bone differentiation when singly implanted in 
heterotopic intramuscular sites of P. ursinus (Ripamonti et al., 
1997; Duneas et al., 1998). The above discoveries casted additional 
and important unexpected functions to the TGF-β
1
 protein in 
primates (Ripamonti et al., 1997). Indeed, TGF-β
1
 implantation 
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bone tissue engineering in clinical contexts, we nevertheless would 
like to venture to list the grand opportunities and challenges ahead 
of the hTGF-β
3
/osteogenic devices for skeletal reconstruction in 
clinical contexts.
The mammalian TGF-β isoforms may regulate the expression 
of the homologous but molecularly different BMPs/OPs, which 
initiate the induction of bone formation. The TGF-β proteins may 
act upstream to the BMPs/OPs and may induce the induction of 
most often the iliac crest with associated harvest-related morbid-
ity. Additional limitations are the finite volume of available bone 
from donor sites and adapting the donor bone to fit the shape of 
the recipient defect, the final challenge to autogenous bone grafting 
in clinical contexts (Ripamonti et al., 2008).
The reported above studies have provided a fascinating scenario 
of “the bone induction principle” (Urist et al., 1967, 1968). Whilst 
it may be construed to be presumptuous to predict the future of 
Figure 2 | Tissue induction and morphogenesis of large and 
corticalized ossicles (A,C) upon implantation of 125 μg hTGF-β3 in the 
Rectus Abdominis muscles of adult baboons Papio ursinus harvested on 
day 90 after heterotopic implantation; (B,D) undecalcified low power view 
of the newly formed ossicles with mineralized bone (in blue) with 
peripheral corticalization  (light blue arrows) enveloping mineralized bone 
covered by osteoid seams  and scattered remnants of collagenous matrix 
as carrier.
Frontiers in Physiology | Craniofacial Biology  November 2010 | Volume 1 | Article 143 | 6
Ripamonti and Klar Regenerative frontiers in craniofacial reconstruction
and Song, F. (2007). Clinical effec-
tiveness and cost-effectiveness of 
bone morphogenetic proteins in the 
non-healing of fractures and spinal 
fusion: a systematic review. Health 
Technol. Assess. 11, 1–150.
Gautschi, O. P., Frey, S. P., and Zellweger, R. 
(2007). Bone morphogenetic proteins 
in clinical applications. ANZ J. Surg. 
77, 626–631.
Govender, S., Csimma, C., Genant, H. K., 
Valentin-Opran, A., Amit, Y., Arbel, R., 
Aro, H., Atar, D., Bishay, M., Borner, 
M. G., Chiron, P., Choong, P., Cinats, 
J., Courtenay, B., Feibel, R., Geulette, 
B., Gravel, C., Haas, N., Raschke, M., 
Hammacher, E., Van Der Velde, D., 
Hardy, P., Holt, M., Josten, C., Ketterl, 
R. L., Lindeque, B., Lob, G., Mathevon, 
H., Mccoy, G., Marsh, D., Miller, R., 
Munting, E., Oevre, S., Nordsletten, 
L., Patel, A., Pohl, A., Rennie, W., 
Reynders, P., Rommens, P. M., Rondia, 
J., Rossouw, W. C., Daneel, P. J., Ruff, S., 
Ruter, A., Santavirta, S., Schildhauer, T. 
A., Gekle, C., Schnettler, R., Segal, D., 
Seiler, H., Snowdowne, R. B., Stapert, 
J., Taglang, G., Verdonk, R., Vogels, L., 
Weckbach, A., Wentzensen, A., and 
Wisniewski, T. (2002). Recombinant 
human bone morphogenetic pro-
tein-2 for treatment of open tibial 
fractures: A prospective, controlled, 
randomized study of four hundred 
and fifty patients. J. Bone Joint Surg. 
Am. 84-A, 2123–2134.
Huggins, C. B. (1968). The forma-
tion of bone under the influence of 
OP-1 cDNA encodes an osteogenic 
 protein in the TGF-β family. EMBO 
J. 9, 2085–2093.
Reddi, A. H. (1984). “Extracellular matrix 
and development,” in Extracellular 
Matrix Biochemistry, eds K. A. Piez, 
and A. H. Reddi (New York: Elsevier), 
375–412.
Reddi, A. H. (1997). Bone morphogenesis 
and modeling: soluble signals sculpt 
osteosomes in the solid state. Cell 89, 
159–161.
Reddi, A. H. (2000). Role of bone mor-
phogenetic proteins in skeletal tissue 
engineering of bone and cartilage: 
inductive signals, stem cells, and bio-
mimetic biomaterials. Tissue Eng. 6, 
351–359.
Reddi, A. H., and Huggins, C. B. (1972). 
Biochemical sequences in the trans-
formation of normal fibroblast in 
adolescent rats. Proc. Natl. Acad. Sci. 
U.S.A. 69, 1601–1605.
Ripamonti, U. (2005). Bone induction 
by recombinant human osteogenic 
protein-1 (hOP-1, BMP-7) in the 
primate Papio ursinus with expres-
sion of mRNA of gene products of 
the TGF-β superfamily. J. Cell. Mol. 
Med. 9, 911–928.
Ripamonti, U. (2006a). Soluble osteogenic 
molecular signals and the induction 
of bone formation. Biomaterials 27, 
807–822.
Ripamonti, U. (2006b). “The Marshall 
Urist awarded lecture – bone: forma-
tion by autoinduction,” in Proceedings 
of the 6th International Conference 
reFerences
Balooch, G., Balooch, M., Nalla, R. K., 
Schilling, S., Filvaroff, E. H., Marshall, 
G. W., Marshall, S. J., Ritchie, R. O., 
Derynck, R., and Alliston, T. (2005). 
Tgf-beta regulates the mechanical 
properties and composition of bone 
matrix. Proc. Natl. Acad. Sci. U.S.A. 
102, 18813–18818.
Crivellato, E., Nico, B., and Ribatti, D. 
(2007). Contribution of endothelial 
cells to organogenesis: a modern reap-
praisal of an old aristotelian concept. 
J. Anat. 211, 415–427.
Duneas, N., Crooks, J., and Ripamonti, U. 
(1998). Transforming growth factor-
beta 1: induction of bone morphoge-
netic protein genes expression during 
endochondral bone formation in the 
baboon, and synergistic interaction 
with osteogenic protein-1 (BMP-7). 
Growth Factors 15, 259–277.
Friedenstein, A. J. (1962). Humoral nature 
of osteogenic activity of transitional 
epithelium. Nature 194, 698–699.
Friedenstein, A. Y. (1968). Induction of 
bone tissue by transitional epithelium. 
Clin. Orthop. Relat. Res. 59, 21–37.
Friedlaender, G. E., Perry, C. R., Cole, J. D., 
Cook, S. D., Cierny, G., Muschler, G. 
F., Zych, G. A., Calhoun, J. H., LaForte, 
A. J., and Yin, S. (2001). Osteogenic 
protein-1 (bone morphogenetic 
protein-7) in the treatment of tibial 
nonunions. J. Bone Joint Surg. Am. 
83A, S151–S158.
Garrison, K. R., Donell, S., Ryder, J., 
Shemilt, I.,Mugford, M.,Harvey, I., 
 epithelium of the urinary tract. Clin. 
Orthop. Relat. Res. 59, 7–19.
Keith, A. (1927). Concerning the origin 
and nature of osteoblasts. Proc. R. Soc. 
Med. 21, 301–308.
Khouri, R. K., Koudsi, B., and Reddi, H. 
(1991). Tissue transformation into 
bone in vivo. A potential practical 
application. ., Am. Med. Assoc. 266, 
1953–1955.
Lacroix, P. (1945). Recent investigations 
on the growth of bone. Nature 156, 
576.
Lanza, D., and Vegetti, M. (1971). Opere 
biologiche di Aristotele. A cura di 
Diego Lanza e Mario Vegetti. Torino: 
UTET.
Lee, C. H., Cook, J. L., Mendelson, A., 
Moioli, E. K., Yao, H., and Mao, J. J. 
(2010). Regeneration of the articular 
surface of the rabbit synovial joint by 
cell homing: a proof of concept study. 
The Lancet 376, 440–448. 
Levander, G. (1938). A study of bone 
regeneration. Surg. Gynecol. Obste. 
67, 705–714.
Levander, G. (1945). Tissue induction. 
Nature 155, 148–149.
Levander, G., and Willestaedt, H. (1946). 
Alcohol-soluble osteogenetic sub-
stance from bone marrow. Nature 
3992, 587.
Moss, M. L. (1958). Extraction of an 
osteogenic inductor factor from bone. 
Science 127, 755–756.
Özkaynak, E., Rueger, D. C., Drier, E. A., 
Corbett, C., Ridge, R. J., Sampath, 
T. K., and Oppermann, H. (1990). 
Finally, we have seen that animal models including non-
human primates may not adequately translate and reproduce 
morphogens-related therapeutic responses in H. sapiens. It is our 
opinion that bone tissue engineering and regenerative medicine 
at large need now to start to systematically identify the molecu-
lar and cellular basis responsible for the differences in healing 
patterns amongst mammals. The concerted genetic and tissue 
biology approaches will break the boundaries of super healing 
(Ripamonti, 2010).
acknowledgments
The reported research work against the dogma on the endo-
chondral osteoinductivity of the non-canonical transforming 
growth factor-β isoforms has been constantly supported by the 
Medical Research Council, the University of the Witwatersrand, 
Johannesburg, and the National Research Foundation of South 
Africa. The authors acknowledge the constructive and unique 
work of a series of technologists and scientists who have worked 
at the Bone Research Laboratory, in particular Barbara van den 
Heever, June Teare, Ruqayya Parak, Louise Renton, Laura Yates, 
Manolis Heliotis, and Carlo Ferretti. We thank Professors Urist 
and Reddi for inspirational scientific insights into “bone: forma-
tion by autoinduction.”
heterotopic bone by expressing selected BMPs/OPs gene products 
ultimately resulting in the induction of bone formation. Current 
and previous studies have shown the expression of BMP-3 and 
OP-1 mRNAs as evaluated by Northern blotting (Duneas et al., 
1998; Ripamonti et al., 2000; Ripamonti and Roden, 2010) and 
RT-PCR analyses (Ripamonti et al., 2008). We have also shown 
that when OP-1 transcription increases, TGF-β
3
 increases expo-
nentially and always remains at a higher level than OP-1 expres-
sion even in extracted macroporous constructs pre-treated with 
hOP-1 (Ripamonti et al., 2010; Ripamonti and Klar, 2010). The 
grand challenges and opportunities for craniofacial and skeletal 
reconstructionists, tissue engineers and molecular biologists alike 
is to now design therapeutic strategies deploying hTGF-β
3
/based 
osteogenic devices in clinical contexts for regeneration of human 
skeletal defects.
The complex signaling patterning controlling bone development 
in both embryonic development and postnatal tissue induction 
and morphogenesis are still long standing scientific problems and 
thus the focus of great curiosity to dissect embryonic develop-
ment and tissue patterning during regenerative medicine; we are 
of the opinion that the hTGF-β
3
/osteogenic device may shed fur-
ther mechanistic and therapeutic insights into “bone: formation 
by autoinduction” (Urist, 1965).
www.frontiersin.org November 2010 | Volume 1 | Article 143 | 7
Ripamonti and Klar Regenerative frontiers in craniofacial reconstruction
Burwell (London: Butterworths 
Heinemann), 316–362.
Urist, M. R., Dowell, T. A., Hay, P. H., 
and Strates, B. S. (1968). Inductive 
substrates for bone formation. Clin. 
Orthop. Relat. Res. 59, 59–96.
Urist, M. R., Silverman, B. F., Buring, K., 
Dubuc, F. L., and Rosenberg, J. M. 
(1967). The bone induction principle. 
Clin. Orthop. Relat. Res. 53, 243–283.
Urist, M. R., and Strates, B. S. (1971). Bone 
morphogenetic protein. J. Dent. Res. 
50, 1392–1406.
von Haller, A. (1763). Experimentorum de 
ossium formatione. Opera minora, Vol. 
2. Lausanne: Francisci Grasset, 400. 
Wozney, J. M., Rosen, V., Celeste, A. J., 
Mitsock, L. M., Whitters, M. J., Kriz, 
R. W., Hewick, R. M., and Wang, E. A. 
(1988). Novel regulators of bone for-
mation: molecular clones and activi-
ties. Science 242, 1528–1534.
Conflict of Interest Statement: The 
authors declare that the research was con-
ducted in the absence of any commercial or 
financial relationships that could be con-
strued as a potential conflict of interest.
Received: 24 August 2010; paper pending 
published: 07 September 2010; accepted: 
08 October 2010; published online: 11 
November 2010.
Citation: Ripamonti U and Klar RM (2010) 
Regenerative frontiers in craniofacial recon-
struction: grand challenges and opportu-
nities for the mammalian transforming 
growth factor-β proteins. Front. Physio. 
1:143. doi: 10.3389/fphys.2010.00143
This article was submitted to Frontiers in 
Craniofacial Biology, a specialty of Frontiers 
in Physiology.
Copyright © 2010 Ripamonti and Klar. 
This is an open-access article subject to 
an exclusive license agreement between 
the authors and the Frontiers Research 
Foundation, which permits unrestricted 
use, distribution, and reproduction in any 
medium, provided the original authors and 
source are credited.
 matrix-associated, bone-inductive 
protein, by heparin affinity chroma-
tography. Proc. Natl. Acad. Sci. U.S.A. 
84, 7109–7113.
Sampath, T. K., and Reddi, A. H. 
(1981). Dissociative extraction and 
 reconstitution of extracellular matrix 
components involved in local bone 
differentiation. Proc. Natl. Acad. Sci. 
U.S.A. 78, 7599–7603.
Sampath, T. K., and Reddi, A. H. (1983). 
Homology of bone-inductive proteins 
from human, monkey, bovine, and rat 
extracellular matrix. Proc. Natl. Acad. 
Sci. U.S.A. 80, 6591–6595.
Sampath, T. K., and Reddi, A. H. (1984). 
Distribution of bone inductive pro-
teins in mineralized and demineralized 
extracellular matrix. Biochem. Biophys. 
Res. Commun. 119, 949–954.
Senn, N. (1889). On the healing of aseptic 
bone cavities by implantation of anti-
septic decalcified bone. Am. J. Med. Sci. 
98, 219–243.
Spagnoli, A., O’Rear, L., Chandler, R. L., 
Granero-Molto, F., Mortlock, D. P., 
Gorska, A. E., Weis, J. A., Longobardi, 
L., Chytil, A., Shimer, K., and Moses, 
H. L. (2007). Tgf-beta signaling is 
essential for joint morphogenesis. J. 
Cell Biol. 177, 1105–1117.
Spemann, H. (1938). Embryonic 
Development and Induction. New 
Haven: Yale University Press.
Sun, P. D. (2003). Conserved in structure 
but diverse in recognition. Structure 
11, 362–363.
Trueta, J. (1963). The role of the vessels in 
osteogenesis. J. Bone Joint Surg. 45B, 
402–418.
Urist, M. R. (1965). Bone: Formation by 
autoinduction. Science 150, 893–899.
Urist, M. R. (1968).The reality of a nebu-
lous enigmatic myth. Clin. Orthop. 
Relat. Res. 59, 3–5.
Urist, M. R. (1994). “The search for and 
discovery of bone morphogenetic 
protein (BMP),” in Bone Grafts, 
Derivatives and Substitutes, eds M. 
R. Urist, B. T. O’Connor, and R. G. 
Ripamonti, U., Ramoshebi, L. N., Teare, 
J., Renton, L., and Ferretti, C. (2008). 
The induction of endochondral bone 
formation by transforming growth 
factor-β3: experimental studies in the 
non-human primate Papio ursinus. J. 
Cell. Mol. Med. 12, 1029–1048.
Ripamonti, U., and Reddi, A. H. (1995). 
Bone morphogenetic proteins: appli-
cations in plastic and reconstructive 
surgery. Adv. Plast. Reconstr. Surg. 11, 
47–73.
Ripamonti, U., and Roden, L. C. (2010). 
Induction of bone formation by 
transforming growth factor-β
2
 in the 
non-human primate Papio ursinus 
and its modulation by skeletal mus-
cle responding stem cells. Cell Prolif. 
43, 207–218.
Ripamonti, U., van den Heever, B., 
Crooks, J., Tucker, M. M., Sampath, 
T. K., Rueger, D. C., and Reddi, A. H. 
(2000). Long-term evaluation of bone 
formation by osteogenic protein 1 in 
the baboon and relative efficacy of 
bone-derived bone morphogenetic 
proteins delivered by irradiated xeno-
geneic collagenous matrices. J. Bone 
Miner. Res. 15, 1798–1809.
Roberts, A. B., Sporn, M. B., Assoian, R. K., 
Smith, J. M., Roche, N. S., Wakefield, 
L. M., Heine, U. I., Liotta, L. A., 
Falanga, V., and Kehrl, J. H. (1986). 
Transforming growth factor type beta: 
rapid induction of fibrosis and ang-
iogenesis in vivo and stimulation of 
collagen formation in vitro. Proc. Natl. 
Acad. Sci. U.S.A. 83, 4167–4171.
Saadeh, P. B., Mehrara, B. J., Steinbrech, 
D. S., Dudziak, M. E., Greenwald, J. 
A., Luchs, J. S., Spector, J. A., Ueno, 
H., Gittes, G. K., and Longaker, M. T. 
(1999). Transforming growth factor-
beta1 modulates the expression of 
vascular endothelial growth factor by 
osteoblasts. Am. J. Physiol. 277(Pt 1), 
C628–C637.
Sampath, T. K., Muthukumaran, N., 
and Reddi, A. H. (1987). Isolation 
of osteogenin, an extracellular 
on Bone Morphogenetic Proteins, 
eds S. Vukicevic and A. H. Reddi, 
(Dubrovnik: Depol Org.), 1.
Ripamonti, U. (2010). Soluble and 
insoluble signals sculpt osteogenesis 
in angiogenesis. World J. Biol. Chem. 
1, 109–132.
Ripamonti, U., Duneas, N., van den Heever, 
B., Bosch, C., and Crooks, J. (1997). 
Recombinant transforming growth 
factor-beta1 induces endochondral 
bone in the baboon and synergizes 
with recombinant osteogenic protein-1 
(bone morphogenetic protein-7) to 
initiate rapid bone formation. J. Bone 
Miner. Res. 12, 1584–1595.
Ripamonti, U., Ferretti, C., and Heliotis, 
M. (2006). Soluble and insoluble 
signals and the induction of bone 
formation: Molecular therapeutics 
recapitulating development. J. Anat. 
209, 447–468.
Ripamonti, U., Heliotis, M., and Ferretti, 
C. (2007). Bone morphogenetic pro-
teins and the induction of bone for-
mation: From laboratory to patients. 
Oral Maxillofac. Surg. Clin. North Am. 
19(4), 575–589, vii.
Ripamonti, U., and Klar, R. (2010). 
Redundancy of Osteogenic Soluble 
Molecular Signals Initiating the 
Induction of Bone Formation. Science 
in Africa, Available at: http://www.
scienceinafrica.co.za/2010/october/
bone_regeneration_full.htm
Ripamonti, U., Klar, R. M., Renton, L. F., 
and Ferretti, C. (2010). Synergistic 
induction of bone formation by 
hOP-1, hTGF-β
3
 and inhibition by 
zoledronate in macroporous coral-
derived hydroxyapatites. Biomaterials 
31, 6400–6410.
Ripamonti, U., Ramoshebi, L. N., Patton, 
J., Matsaba, T., Teare, J., and Renton, 
L. (2004). “Soluble signals and insol-
uble substrata: novel molecular cues 
instructing the induction of bone,” 
in The Skeleton, eds E. J. Massaro, J. 
M. Rogers (Totowa: Human Press), 
217–227.
